Abingdon Health targets further growth after swinging to half-year profit
Abingdon Health has cut its annual losses and returned to adjusted EBITDA profitability in the second half as the rapid diagnostics group looks to build on a year of strong revenue growth.
The York-based business increased total revenues, including grant-funded income, by 32% to £11.3m in the year to 30 June 2026, up from £8.6m a year earlier.
Its adjusted EBITDA loss narrowed from £2.6m to £1.5m, while its loss before tax fell from £3.5m to £2m.
Gross margin improved to 47.1% from 44.3%, and cash balances rose to £2.9... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
